TABITHA ARRINGTON: Open Payments
NPI 1225646110 · SOUTHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,562 in 64 payments from 12 companies in 2025. Trend: 2023 $1,158 · 2024 $1,601 · 2025 $1,562
Food & beverage: $1,562
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 13 | $425 |
| Vanda Pharmaceuticals Inc. | 7 | $217 |
| ABBVIE INC. | 7 | $208 |
| Supernus Pharmaceuticals, Inc. | 8 | $165 |
| Collegium Pharmaceutical, Inc. | 9 | $152 |
| Corium, LLC | 7 | $95 |
| Tris Pharma Inc | 3 | $66 |
| Lundbeck LLC | 2 | $56 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| Biogen, Inc. | 2 | $47 |
Products named: Auvelity, FANAPT, VRAYLAR, Qelbree, Jornay PM, REXULTI, Azstarys, ZURZUVAE.
Industry payments across MS — which companies pay providers there.
